Insys Therapeutics - 19 Year Stock Price History | INSY

Historical daily share price chart and data for Insys Therapeutics since 2000 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Insys Therapeutics as of January 23, 2019 is 4.02.
Insys Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 4.3533 4.3500 4.6700 4.0200 4.0200 14.86%
2018 7.5309 11.5300 13.3800 3.4700 3.5000 -63.62%
2017 9.8283 9.8600 14.7000 4.9700 9.6200 4.57%
2016 14.9835 28.0500 28.0500 9.0700 9.2000 -67.87%
2015 30.5712 21.0950 44.9200 21.0950 28.6300 35.82%
2014 17.8493 13.3267 27.7900 11.3000 21.0800 63.37%
2013 7.3685 2.5000 16.3600 2.3667 12.9033 399.49%
2012 3.3651 3.3367 6.2333 2.3333 2.5833 -13.89%
2011 4.7088 5.2867 7.8080 1.3333 3.0000 -45.36%
2010 6.4800 6.5067 8.9467 4.4733 5.4900 -6.90%
2009 4.5419 3.4567 10.9800 0.7117 5.8967 78.90%
2008 8.9350 13.0133 17.4846 2.0333 3.2960 -72.53%
2007 26.9241 35.3800 46.7667 11.9967 11.9967 -64.67%
2006 141.1875 222.8533 253.5567 33.9567 33.9567 -84.52%
2005 208.9988 247.4567 310.8967 148.0267 219.3967 -13.75%
2004 256.5310 365.1867 451.1967 99.4300 254.3700 -31.34%
2003 273.8244 187.4203 388.3667 155.2406 370.4733 106.64%
2002 259.8843 425.9391 438.3159 174.3362 179.2870 -59.52%
2001 342.7820 586.6930 586.6930 222.4611 442.9130 -27.26%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.305B $0.141B
Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's cancer-supportive care and cancer therapy product candidates include Fentanyl sublingual spray and Dronabinol SG capsule. Insys Therapeutics, Inc. is based in Phoenix, Arizona.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $125.560B 25.44
Medtronic (MDT) Ireland $116.845B 17.47
Stryker (SYK) United States $62.070B 23.40
Boston Scientific (BSX) United States $51.560B 26.06
Baxter (BAX) United States $37.069B 23.94
Zimmer Biomet Holdings (ZBH) United States $21.197B 13.75
ResMed (RMD) United States $16.739B 31.92
Smith & Nephew SNATS (SNN) United Kingdom $16.480B 0.00
Canopy Growth (CGC) Canada $10.136B 0.00
Bio-Rad Laboratories (BIO) United States $7.056B 45.12
Hill-Rom Holdings (HRC) United States $6.447B 20.36
Aurora Cannabis (ACB) Canada $6.178B 32.58
Perrigo (PRGO) Ireland $6.105B 9.27
Haemonetics (HAE) United States $5.072B 44.61
ICU Medical (ICUI) United States $4.894B 27.27
Insulet (PODD) United States $4.517B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.200B 0.00
Neogen (NEOG) United States $3.138B 48.21
Agios Pharmaceuticals (AGIO) United States $3.041B 0.00
Hutchison China MediTech (HCM) China $2.918B 0.00
National Vision Holdings (EYE) United States $2.467B 47.72
NuVasive (NUVA) United States $2.457B 22.87
Quidel (QDEL) United States $2.042B 26.63
NxStage Medical (NXTM) United States $1.891B 0.00
Aphria (APHA) $1.768B 78.67
Phibro Animal Health (PAHC) United States $1.259B 17.82
AtriCure (ATRC) United States $1.203B 0.00
VAREX IMAGING (VREX) United States $1.038B 20.79
Cardiovascular Systems (CSII) United States $1.001B 1441.00
PetIQ (PETQ) United States $0.788B 20.43
Cerus (CERS) United States $0.764B 0.00
OraSure Technologies (OSUR) United States $0.739B 41.59
Meridian Bioscience (VIVO) United States $0.703B 22.42
Omeros (OMER) United States $0.651B 0.00
Surmodics (SRDX) United States $0.645B 97.61
Eagle Pharmaceuticals (EGRX) United States $0.627B 20.11
Lantheus Holdings (LNTH) United States $0.625B 19.36
NanoString Technologies (NSTG) United States $0.623B 0.00
MacroGenics (MGNX) United States $0.487B 0.00
Owens & Minor (OMI) United States $0.481B 5.44
Quanterix (QTRX) United States $0.449B 0.00
LeMaitre Vascular (LMAT) United States $0.449B 22.04
Evolus (EOLS) United States $0.443B 0.00
TG Therapeutics (TGTX) United States $0.361B 0.00
Utah Medical Products (UTMD) United States $0.314B 20.31
Bovie Medical (APYX) United States $0.280B 0.00
Vapotherm (VAPO) United States $0.273B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.268B 0.00
Cytosorbents (CTSO) United States $0.230B 0.00
BioLife Solutions (BLFS) United States $0.229B 310.00
Rockwell Medical (RMTI) United States $0.178B 0.00
Fonar (FONR) United States $0.137B 6.88
Chimerix (CMRX) United States $0.132B 0.00
Surface Oncology (SURF) United States $0.132B 0.00
Chembio Diagnostics (CEMI) United States $0.120B 0.00
United-Guardian (UG) United States $0.086B 18.00
Female Health (VERU) United States $0.085B 0.00
InfuSystems Holdings (INFU) United States $0.069B 0.00
Trinity Biotech (TRIB) Ireland $0.060B 16.73
Oramed Pharmaceuticals (ORMP) United States $0.059B 0.00
CAS Medical Systems (CASM) United States $0.056B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Neurotrope (NTRP) United States $0.031B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.020B 0.00
Senestech (SNES) United States $0.019B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00